Financials

  • Market Capitalization 26.39 M
  • Employee 19
  • Founded 2015
  • CEO N/A
  • Website www.abvcpharma.com
  • Headquarter Nevada, United States
  • FIGI BBG000Q844Z2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.46
Rapporto prezzo/fatturato
—

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4396
RNAZ
TransCode Therapeutics, Inc. - Common Stock
1.63 USD-12.37%-7.91%-1.21%-82.86%27.60 M USD
4405
MCRB
Seres Therapeutics, Inc. - Common Stock
2.68 USD-1.11%-6.94%-46.40%-67.44%26.64 M USD
4415
BYSI
BeyondSpring, Inc. - Ordinary Shares
0.62 USD+1.64%-18.42%-18.42%-63.53%25.49 M USD
4419
EVAX
Evaxion A/S - American Depositary Share
3.00 USD-2.28%-7.41%-5.36%-9.64%25.02 M USD

Notizie